GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Cyclically Adjusted PS Ratio

Sun Pharmaceuticals Industries (BOM:524715) Cyclically Adjusted PS Ratio : 9.92 (As of May. 06, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Cyclically Adjusted PS Ratio?

As of today (2025-05-06), Sun Pharmaceuticals Industries's current share price is ₹1818.75. Sun Pharmaceuticals Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ₹183.34. Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio for today is 9.92.

The historical rank and industry rank for Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:524715' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.75   Med: 5.94   Max: 10.86
Current: 10.01

During the past years, Sun Pharmaceuticals Industries's highest Cyclically Adjusted PS Ratio was 10.86. The lowest was 2.75. And the median was 5.94.

BOM:524715's Cyclically Adjusted PS Ratio is ranked worse than
91.94% of 732 companies
in the Drug Manufacturers industry
Industry Median: 2.03 vs BOM:524715: 10.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sun Pharmaceuticals Industries's adjusted revenue per share data for the three months ended in Dec. 2024 was ₹55.999. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹183.34 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sun Pharmaceuticals Industries Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Cyclically Adjusted PS Ratio Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.89 4.60 6.29 6.05 9.20

Sun Pharmaceuticals Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.22 9.20 8.48 10.59 10.28

Competitive Comparison of Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio falls into.


;
;

Sun Pharmaceuticals Industries Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1818.75/183.34
=9.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Sun Pharmaceuticals Industries's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=55.999/158.3229*158.3229
=55.999

Current CPI (Dec. 2024) = 158.3229.

Sun Pharmaceuticals Industries Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 29.453 97.163 47.992
201506 27.004 99.841 42.822
201509 28.664 101.753 44.600
201512 29.360 102.901 45.173
201603 30.897 102.518 47.715
201606 33.071 105.961 49.413
201609 32.243 105.961 48.176
201612 31.843 105.196 47.925
201703 29.003 105.196 43.650
201706 25.687 107.109 37.969
201709 27.455 109.021 39.871
201712 27.495 109.404 39.789
201803 28.198 109.786 40.664
201806 29.776 111.317 42.350
201809 28.442 115.142 39.108
201812 31.938 115.142 43.916
201903 29.347 118.202 39.308
201906 34.407 120.880 45.065
201909 33.094 123.175 42.537
201912 33.527 126.235 42.049
202003 33.633 124.705 42.700
202006 31.198 127.000 38.892
202009 35.530 130.118 43.232
202012 36.615 130.889 44.289
202103 34.975 131.771 42.023
202106 40.173 134.084 47.435
202109 39.683 135.847 46.249
202112 40.996 138.161 46.979
202203 38.819 138.822 44.272
202206 44.417 142.347 49.402
202209 44.914 144.661 49.156
202212 46.122 145.763 50.096
202303 44.929 146.865 48.434
202306 48.946 150.280 51.566
202309 50.023 151.492 52.279
202312 50.578 152.924 52.364
202403 49.488 153.035 51.198
202406 52.119 155.789 52.967
202409 55.410 157.882 55.565
202412 55.999 158.323 55.999

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sun Pharmaceuticals Industries  (BOM:524715) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sun Pharmaceuticals Industries Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines